Rahem Fertility Center of Zagazig, Egypt Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04507022
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

faculty of human medicine,zagazig university | Rahem Fertility Center | Rahem Fertility Center of Zagazig, Egypt

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Infertility, Female (Phase 4)

Infertility, Male (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5